Skip to main
EPRX
EPRX logo

EPRX Market Capitalization Overview

Market Cap: $193.27M as of Jul 2, 2025

$193.27M
Past Month+$52.03M (36.83%)
As of Jul 2, 2025, EPRX has a market capitalization of $193.27M. Over the past 30 days, its market cap has increased by 48.22%, while in the last 12 months, it has increased by 71.15%.

Market capitalization represents the total value of Eupraxia Pharmaceuticals Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

EPRX Market Cap Formula = Stock Price * Shares Outstanding

The market cap of EPRX helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

EPRX Market Cap History

DateMarket CapChange
Jul 1, 2025$209.37M+48.22%
Jun 2, 2025$141.25M+2.07%
May 1, 2025$138.38M+17.71%
Apr 1, 2025$117.56M-16.15%
Mar 3, 2025$140.21M+29.76%
Feb 3, 2025$108.06M-3.09%
Jan 2, 2025$111.50M-7.94%

EPRX End of Year Market Cap History

DateMarket CapChange
2025$193.27M+71.15%
2024$112.93M-0.46%
2023$113.45M+97.14%
2022$57.55M+75.67%
2021$32.76M

FAQs About Eupraxia Pharmaceuticals Inc (EPRX) Market Cap

As of Jul 2, 2025, the market capitalization of EPRX is $193.27M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Eupraxia Pharmaceuticals Inc’s market capitalization has increased by 36.83%, changing from $141.25M to $193.27M as of Jul 2, 2025.

In the last 3 months, Eupraxia Pharmaceuticals Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Eupraxia Pharmaceuticals Inc’s market capitalization decreased from $113.45M in January to $112.93M in December, reflecting a -0.46% change.

In the past five years, EPRX has had a compound annual growth rate (CAGR) of 36.26% in market capitalization. This means its market cap has grown at an average rate of 36.26% per year.

Eupraxia Pharmaceuticals Inc (EPRX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.